ArticleFrontiers in medicine2024

Lipid safety of tenofovir alafenamide during 96-week treatment in treatment-naive chronic hepatitis B patients.

Wenjuan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.